HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victor Martínez-Taboada Selected Research

Infections

6/2020Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Victor Martínez-Taboada Research Topics

Disease

1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2020
1Eye Diseases (Eye Disease)
06/2020
1Heart Failure
06/2020
1Hypersensitivity (Allergy)
06/2020
1Infections
06/2020
1Liver Diseases (Liver Disease)
06/2020
1Macular Degeneration (Age-Related Maculopathy)
06/2020
1Neoplasms (Cancer)
06/2020
1Pneumonia (Pneumonitis)
06/2020
1Asymptomatic Infections
06/2020
1Mental Disorders (Mental Disorder)
06/2020
1Rheumatic Diseases (Rheumatism)
12/2016

Drug/Important Bio-Agent (IBA)

2AntibodiesIBA
06/2020 - 12/2016
1Antiphospholipid AntibodiesIBA
10/2020
1Chloroquine (Aralen)FDA LinkGeneric
06/2020
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
06/2020
1Immunoglobulin A (IgA)IBA
06/2020
1Immunoglobulin G (IgG)IBA
06/2020
1Immunoglobulin M (IgM)IBA
06/2020
1Raloxifene Hydrochloride (Evista)FDA Link
06/2020
1TabletsIBA
06/2020
1TamoxifenFDA LinkGeneric
06/2020
1Antinuclear AntibodiesIBA
12/2016

Therapy/Procedure

1Oral Administration
06/2020
1Contraindications
06/2020
1Chemoprevention
06/2020